ImmunoPrecise Antibodies Ltd.
NASDAQ:IPA
0.46 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 24.518 | 20.665 | 19.364 | 17.912 | 14.058 | 10.926 | 5.441 | 2.631 | 1.896 | 1.764 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.008 | 0.053 | 0 | 0.007 |
| Cost of Revenue
| 12.465 | 9.102 | 8.381 | 6.374 | 6.024 | 5.632 | 2.99 | 1.21 | 0.298 | 0.265 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 12.053 | 11.563 | 10.983 | 11.538 | 8.034 | 5.295 | 2.451 | 1.421 | 1.598 | 1.498 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.008 | 0.053 | 0 | 0.007 |
| Gross Profit Ratio
| 0.492 | 0.56 | 0.567 | 0.644 | 0.571 | 0.485 | 0.45 | 0.54 | 0.843 | 0.85 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 4.043 | 12.28 | 6.693 | 1.974 | 0.446 | 0.486 | 0.509 | 0.66 | 0.303 | 0.622 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 15.592 | 19.812 | 16.97 | 12.648 | 7.95 | 7.649 | 6.311 | 6.703 | 0.997 | 0.065 | 0.095 | 0.08 | 0.206 | 0.253 | 0.256 | 0.361 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 3.543 | 3.608 | 0.74 | 0.691 | 0.378 | 0.819 | 0.135 | 0.119 | 0.021 | 0.007 | 0 | 0 | 0 | 0.006 | 0.009 | 0.039 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 19.135 | 23.42 | 17.71 | 13.339 | 8.328 | 8.469 | 6.446 | 6.822 | 1.018 | 0.065 | 0.095 | 0.08 | 0.206 | 0.259 | 0.265 | 0.4 | 0.612 | 0.23 | 0.203 | 0.197 | 0.307 | 0.156 | 0.192 | 0.148 | 0.182 | 0.23 | 0.276 | 0.225 |
| Other Expenses
| -11.125 | 0 | 2.75 | 0.132 | 2.653 | 1.915 | 0.257 | 0.377 | 0.34 | 0.001 | 0.003 | 0.012 | 0.002 | 0.163 | 1.083 | 0.061 | 0.131 | 0.237 | 0.206 | 0.002 | 0.078 | 0.158 | -0.003 | 0.149 | -0.014 | 0 | -0.487 | 0.228 |
| Operating Expenses
| 12.053 | 39.782 | 27.153 | 15.714 | 12.081 | 11.52 | 7.212 | 7.841 | 1.661 | 0.066 | 0.097 | 0.081 | 0.208 | 0.261 | 0.269 | -0.071 | 0.616 | 0.237 | 0.206 | 0.2 | 0.309 | 0.158 | 0.194 | 0.149 | 0.184 | 0.232 | 0.279 | 0.228 |
| Operating Income
| -13.762 | -26.091 | -15.781 | -6.653 | -4.094 | -6.227 | -4.929 | -1.386 | 0.243 | -0.037 | -0.098 | -0.081 | -0.208 | -0.265 | -0.295 | -0.403 | -1.224 | -0.417 | -0.4 | -0.201 | -0.642 | -0.158 | -0.233 | -0.149 | -1.23 | -1.25 | -0.37 | -0.222 |
| Operating Income Ratio
| -0.561 | -1.263 | -0.815 | -0.371 | -0.291 | -0.57 | -0.906 | -0.527 | 0.128 | -0.021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -603.207 | -450.245 | -162.193 | -23.703 | -6,168.95 | -33.963 |
| Total Other Income Expenses Net
| -14.941 | -2.141 | -0.067 | -2.078 | -1.467 | -1.09 | -0.518 | -4.08 | 0.221 | -0.025 | 0.167 | -0.014 | -0.068 | -5.006 | -1.09 | -0.07 | 0.131 | 0.012 | -0.006 | 0 | -0.256 | -0.126 | -0.041 | 0.015 | 1.23 | 1.25 | -0.578 | -0.524 |
| Income Before Tax
| -28.703 | -27.752 | -15.848 | -5.995 | -5.293 | -7.613 | -5.061 | -5.466 | 0.243 | -0.062 | 0.069 | -0.096 | -0.276 | -5.271 | -1.385 | -0.473 | -1.093 | -0.405 | -0.406 | -0.201 | -0.898 | -0.284 | -0.274 | -0.134 | -2.299 | -2.32 | -0.948 | -0.745 |
| Income Before Tax Ratio
| -1.171 | -1.343 | -0.818 | -0.335 | -0.377 | -0.697 | -0.93 | -2.078 | 0.128 | -0.035 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -710.689 | -405.973 | -303.035 | -44.006 | -15,803.867 | -114.209 |
| Income Tax Expense
| -1.526 | -1.192 | 0.861 | 1.345 | -0.346 | 0.005 | 0.11 | -0.082 | 0.092 | 0 | 0 | 0 | 0 | 0.166 | -0.394 | 0.062 | -0.336 | 0.168 | -0.572 | -0.011 | 0.334 | 0 | 0.039 | 0 | 1.054 | 1.072 | -0.002 | -0.025 |
| Net Income
| -27.177 | -26.56 | -16.709 | -7.34 | -4.947 | -7.617 | -5.171 | -5.384 | 0.151 | -0.062 | 0.069 | -0.096 | -0.276 | -5.271 | -0.991 | -0.473 | -0.757 | -0.405 | 0.166 | -0.187 | -0.565 | -0.284 | -0.235 | -0.134 | -1.245 | -1.251 | -0.764 | -0.72 |
| Net Income Ratio
| -1.108 | -1.285 | -0.863 | -0.41 | -0.352 | -0.697 | -0.95 | -2.047 | 0.08 | -0.035 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -609.863 | -406.961 | -164.145 | -23.717 | -12,732.867 | -110.412 |
| EPS
| -1.06 | -1.07 | -0.85 | -0.45 | -0.36 | -0.61 | -0.57 | -1.36 | 0.1 | -0.11 | 0.11 | -0.18 | -0.5 | -9.58 | -1.8 | -1 | -1.81 | -1.07 | 0.45 | -0.6 | -2.4 | -1.29 | -1.32 | -0.88 | -8.17 | -8.21 | -5.03 | -4.74 |
| EPS Diluted
| -1.06 | -1.07 | -0.85 | -0.45 | -0.36 | -0.61 | -0.57 | -1.36 | 0.1 | -0.11 | 0.11 | -0.18 | -0.5 | -9.58 | -1.8 | -1 | -1.81 | -1.07 | 0.45 | -0.6 | -2.17 | -1.29 | -1.32 | -0.88 | -8.17 | -8.21 | -5.03 | -4.74 |
| EBITDA
| -22.949 | -21.037 | -11.994 | -1.419 | -0.449 | -4.031 | -4.321 | -5.399 | 0.294 | 0.369 | -0.096 | -0.08 | -0.206 | -0.096 | -1.35 | -0.47 | -0.004 | -0.051 | -0.008 | -0.196 | 0.027 | -0.156 | -0.191 | -0.148 | -0.174 | -0.177 | -0.276 | -0.219 |
| EBITDA Ratio
| -0.936 | -1.029 | -0.626 | -0.01 | -0.026 | -0.36 | -0.815 | -1.961 | 0.146 | -0.037 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -394.938 | -447.679 | 116.01 | 16.944 | -3,082.217 | -33.487 |